Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 3/20 | 0.49 |
| ▸ | STAT3 | P40763 | 1/20 | 0.48 |
| ▸ | STAT1 | P42224 | 1/20 | 0.48 |
| ▸ | TOP1 | P11387 | 4/20 | 0.48 |
| ▸ | CYCS | P99999 | 4/20 | 0.47 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.46 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL479431 | 1.00 | TERT (0.49) | TERTSTAT3STAT1TOP1CYCS | |
| SCHEMBL5016668 | 1.00 | TERT (0.49) | TERTSTAT3STAT1TOP1CYCS | |
| SCHEMBL9581910 | 0.91 | TERT (0.45) | TERTTOP1CYCSABCG2ENPP2 | |
| SCHEMBL29408466 | 0.91 | TERT (0.45) | TERTTOP1CYCSABCG2ENPP2 | |
| SCHEMBL17251727 | 0.90 | TOP1 (0.43) | TERTSTAT3STAT1TOP1CYCS | |
| SCHEMBL17251726 | 0.87 | TOP1 (0.58) | TERTSTAT3STAT1TOP1CYCS | |
| SCHEMBL18613121 | 0.85 | ABCG2 (0.44) | TERTTOP1CYCSABCG2ENPP2 | |
| SCHEMBL8014529 | 0.84 | TOP1 (0.62) | TERTSTAT3STAT1TOP1CYCS | |
| SCHEMBL8014524 | 0.84 | TOP1 (0.62) | TERTSTAT3STAT1TOP1CYCS | |
| SCHEMBL18593558 | 0.84 | TOP1 (0.45) | TERTTOP1CYCSABCG2ENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7417142-B2 | Chiral porphyrins, chiral metalloporphyrins, and methods for synthesis of the same | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, INC. (US) | 2008-08-26 | — | — | US | disclosed |
| US-20060030718-A1 | Cobalt-based catalysts for the cyclization of alkenes | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2006-02-09 | — | — | US | disclosed |
| US-20050124596-A1 | Chiral porphyrins, chiral metalloporphyrins, and methods for synthesis of the same | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2005-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060030718-A1 | Cobalt-based catalysts for the cyclization of alkenes | PPOX, HCCS, ICOSLG | TERT 645/4885STAT3 3817/4885STAT1 4312/4885 |
| US-20050124596-A1 | Chiral porphyrins, chiral metalloporphyrins, and methods for synthesis of the same | PPOX, PPIF, HMBS | TERT 1385/4885STAT3 2986/4885STAT1 3579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.